Lecci A, Borsini F, Gragnani L, Volterra G, Meli A
Pharmacological Research Department, A. Menarini Pharmaceuticals, Firenze, Italy.
J Neural Transm Gen Sect. 1991;83(1-2):67-76. doi: 10.1007/BF01244453.
Stress-induced hyperthermia (SIH), which is seen in the last mice removed from the cage, is a novel animal model sensitive to anxiolytic drugs. SIH is antagonized by CL 218872 (25 and 50 mg/kg, os), by tracazolate (5 and 7.5 mg/kg, ip) and by 2-AP-5 (50 and 100 mg/kg, ip). At higher dose, CL 218872 (100 mg/kg, os) and tracazolate (12.5 mg/kg, ip) lose their activity. PK 9084 (5-40 mg/kg, ip) and CGS 9896 (2-20 mg/kg, both ip and os) were also ineffective in preventing SIH. The anti-hyperthermic effect of CL 218872 (25 mg/kg) and tracazolate (7.5 mg/kg) was blocked by the benzodiazepine antagonist Ro 15-1788 (15 mg/kg), CGS 9896 (10 mg/kg, os) also reversed the effect of CL 218872 (25 mg/kg) on SIH. Differently from anxiolytics, MK-801 (0.5-1 mg/kg, os), PCP (2.5 mg/kg, ip) and d-amphetamine (10 mg/kg, ip) evoked hyperthermia in the first set of mice and prevented a further stress-induced rise of body temperature in the last set of mice.
应激性体温过高(SIH)见于最后从笼中取出的小鼠,是一种对抗焦虑药物敏感的新型动物模型。CL 218872(25和50毫克/千克,口服)、曲卡唑酯(5和7.5毫克/千克,腹腔注射)和2-AP-5(50和100毫克/千克,腹腔注射)可拮抗SIH。在较高剂量时,CL 218872(100毫克/千克,口服)和曲卡唑酯(12.5毫克/千克,腹腔注射)失去活性。PK 9084(5-40毫克/千克,腹腔注射)和CGS 9896(2-20毫克/千克,腹腔注射和口服)在预防SIH方面也无效。CL 218872(25毫克/千克)和曲卡唑酯(7.5毫克/千克)的抗体温过高作用被苯二氮䓬拮抗剂Ro 15-1788(15毫克/千克)阻断,CGS 9896(10毫克/千克,口服)也逆转了CL 218872(25毫克/千克)对SIH的作用。与抗焦虑药不同,MK-801(0.5-1毫克/千克,口服)、苯环己哌啶(2.5毫克/千克,腹腔注射)和右旋苯丙胺(10毫克/千克,腹腔注射)在第一组小鼠中诱发体温过高,并在最后一组小鼠中防止进一步的应激诱导体温升高。